Abstract: Objective： To analyze the effect and compliance of individualized follow-up guidance based on the network platform on blood glucose control in patients using basal insulin for the first time. Methods：From January 2018 to May 2019， 539 patients who first used basal insulin in the First Affiliated Hospital of Dali University were given individualized follow-up guidance on the network platform. The general information and blood glucose monitoring data at various stages of the follow-up patients were retrospectively analyzed， and multiple linear regression analysis was performed on many factors. Results： During the follow-up period， the rate of fasting blood glucose up to standard was （69.73±3.25）%， and the rate of up to 2 h postprandial blood glucose was （74.63±1.49）%. Multiple linear regression analysis found that there was a correlation between the initial fasting blood glucose and the initial insulin dose（P<0.05）， and there was a correlation between the blood glucose at 2 h after meals when included in the study group and the course of disease， age and body mass index（P<0.05）. Conclusion： The individualized follow-up guidance based on the network platform can improve the glycemic control effect of the first-time insulin users and improve the patient's treatment compliance with insulin medication.

Key words: font-family:Times New Roman, ">individualized follow-up guidancefont-family:Times New Roman, ">, font-family:Times New Roman, "> basal insulinfont-family:Times New Roman, ">, font-family:Times New Roman, "> blood glucose targetfont-family:Times New Roman, ">, font-family:Times New Roman, "> compliance